Clinical Trial: A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants

U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07341672) titled 'A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants' on Dec. 23, 2025.

Brief Summary: Evaluate the pharmacokinetic effects of itraconazole, fluconazole, or efavirenz on a single - dose of Clifutinib and the safety of the combination therapy in healthy participants.

Study Start Date: March 04

Study Type: INTERVENTIONAL

Condition: Healthy Adult Subject

Intervention: DRUG: Clifutinib

The subjects are required to take Clifutinib on an empty stomach for at least 10 hours and w...